Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Neurology|January 7, 2015
Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorderSu-Hyun Kim, Jae-Won Hyun, In Hye Jeong, et al.
Glia|September 25, 2008
Matrix metalloproteinase-2 is involved in myelination of dorsal root ganglia neuronsHelmar C Lehmann, Angelika Köhne, Fabian Bernal, et al.
Neurology|September 20, 2013
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosisClemens Warnke, Anne K Mausberg, Mark Stettner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 17, 2010
CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virusClemens Warnke, Vsevolod Smolianov, Thomas Dehmel, et al.
Annals of Clinical and Translational Neurology|March 10, 2015
Fingolimod treatment promotes regulatory phenotype and function of B cellsBerit Grützke, Stephanie Hucke, Catharina C Gross, et al.
Annals of Clinical and Translational Neurology|February 3, 2015
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20bJens Ingwersen, Til Menge, Britta Wingerath, et al.
Annals of Clinical and Translational Neurology|January 4, 2018
Infectious risk stratification in multiple sclerosis patients receiving immunotherapyJonas Graf, Verena I Leussink, Thomas Dehmel, et al.
Human Molecular Genetics|October 4, 2011
Charcot-Marie-Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potentialRebecca Noack, Svenja Frede, Philipp Albrecht, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSFClemens Warnke, Mark Stettner, Vera Lehmensiek, et al.
Pageof 4